{"data":{"filter_options":{"titles":[{"name":"Partner","value":"Partner"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Attorney","value":"Attorney"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":2839},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Atlanta's John Marshall Law School","value":2830},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Bond University","value":2841},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Bucerius Law School, Germany","value":2898},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"Chicago-Kent College of Law","value":3050},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"College of Law, Guildford, UK","value":2646},{"name":"College of Law, London, UK","value":2647},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"Delhi University","value":3099},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Durham University","value":2708},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Elisabeth Haub School of Law at Pace University","value":2936},{"name":"ELTE University Budapest","value":2969},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":3039},{"name":"Faculty of Law","value":2944},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce School of Law","value":2259},{"name":"Free University Berlin","value":2903},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"Fudan University","value":2986},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Guildhall University, London","value":2863},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"Inns of Court School of Law, UK","value":2649},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johannes Gutenberg-University, Mainz, Germany","value":2653},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"King Saud University College of Law \u0026 Political Sciences","value":2823},{"name":"King's College London","value":2987},{"name":"King's College, University of London, UK","value":2654},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Leiden University","value":2926},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"Liverpool University, UK","value":2657},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"London School of Economics and Political Science, UK","value":2658},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Ludwig Maximilian University of Munich","value":3105},{"name":"Lund University","value":3084},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Monash University, Australia","value":3047},{"name":"Monash University, Australia","value":2660},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"New York University School of Law","value":2715},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Oxford University, UK","value":2669},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queen's University Faculty of Law","value":2801},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Saint Louis University School of Law","value":2725},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Sciences Po Paris","value":2925},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Manchester","value":2845},{"name":"The University of Melbourne","value":2836},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Texas School of Law","value":2752},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad del Rosario, Bogotá Colombia","value":2677},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Iberoamericana","value":2915},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"Université Catholique de Louvain, Licencie en Droit","value":3213},{"name":"Universite Libre de Bruxelles, Belgium","value":2679},{"name":"Université Paris I Panthéon-Sorbonne","value":2680},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University College London, UK","value":2760},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Augsburg","value":2779},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of Bonn, Germany","value":2682},{"name":"University of Bristol, UK","value":2761},{"name":"University of Buenos Aires, Argentina","value":2683},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Cambridge, UK","value":2684},{"name":"University of Canterbury","value":2981},{"name":"University of Cape Town, South Africa","value":2854},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Cologne, Germany","value":2885},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of Deusto, Spain","value":2685},{"name":"University of East Anglia","value":3000},{"name":"University of East London","value":2963},{"name":"University of Exeter, UK","value":2770},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Florida, Levin College of Law","value":3112},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Hamburg, Germany","value":2688},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois at Chicago School of Law","value":2202},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kent at Canterbury, UK","value":2690},{"name":"University of Kent","value":2849},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Law","value":2954},{"name":"University of Leeds School of Law","value":2850},{"name":"University of Lethbridge","value":3030},{"name":"University of Lima","value":2859},{"name":"University of London","value":2692},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Maryland School of Law","value":2739},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":3064},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of New South Wales","value":2871},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Nottingham, England","value":2881},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Otago, New Zealand","value":2694},{"name":"University of Paris II, Pantheon-Assas, France","value":2695},{"name":"University of Paris, Pantheon Sorbonne","value":3190},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of Sheffield","value":2805},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Sydney, Australia","value":2700},{"name":"University of Tasmania","value":2835},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Tokyo","value":3153},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Turku","value":3083},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Warwick, UK","value":2771},{"name":"University of Washington School of Law","value":2412},{"name":"University of Western Australia","value":2949},{"name":"University of Wisconsin Law School","value":2755},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wollongong, Australia","value":2873},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"University Toulouse Capitol","value":3109},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"112","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"M","per_page":12,"people":[{"id":436361,"version":1,"owner_type":"Person","owner_id":2118,"payload":{"bio":"\u003cp\u003eKatie McCarthy focuses on trademark, copyright, design, advertising and internet law. As a partner in our Intellectual Property, Patent, Trademark and Copyright Litigation practice, Katie represents clients in a wide array of industries including consumer products, pharmaceuticals, retail, internet services, sports and entertainment, cosmetics, and food and beverages. Katie appears on behalf of clients in federal court and before the U.S. Patent and Trademark Office's Trademark Trial and Appeal Board. Katie also develops domestic and international protection and enforcement programs.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDuring her more than 30 years of experience, Katie has first-chaired numerous trials and preliminary injunction hearings. Katie actively polices online infringement and scams for several clients. In addition to litigation and contested matters, Katie directs international and domestic trademark clearance and prosecution programs, manages domain name disputes and acquisitions, and develops social media and other intellectual property-related policies.\u003c/p\u003e\n\u003cp\u003eKatie also counsels clients on a broad range of IP-related matters, helping to find creative and practical solutions to legal challenges, and developing legal strategies and policies that advance their business goals.\u003c/p\u003e\n\u003cp\u003eKatie has served on the Board of the New York Intellectual Property Law Association for years, recently finishing a term as President during which she organized and moderated a forum of key discussion leaders debating online platform liability. Katie served as Editor-in-Chief of the International Trademark Association peer-reviewed scholarly journal,\u0026nbsp;\u003cem\u003eThe Trademark Reporter\u003c/em\u003e, having\u003cem\u003e\u0026nbsp;\u003c/em\u003eserved on the committee soliciting and editing articles for the journal for more than 20 years. Katie\u0026rsquo;s article, \u0026ldquo;Free Ride or Free Speech: Predicting Results and Providing Advice for Trademark Disputes Involving Parody\u0026rdquo; won INTA\u0026rsquo;s 2020 Ladas Memorial Award for best paper in the professional category. Katie has presented at and co-chaired PLI's IP Enforcement Update program annually since 2011 and frequently writes and speaks for PLI, INTA, NYIPLA and other organizations on trademark, copyright and false advertising topics.\u0026nbsp; Katie is the author of PLI\u0026rsquo;s one volume treatise, \u0026ldquo;Kane on Trademark Law: A Practitioner\u0026rsquo;s Guide.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003eKatie has been recognized in the 2012\u0026ndash;2016 editions of\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;for her trademark work.\u003c/p\u003e","slug":"kathleen-mccarthy","email":"kmccarthy@kslaw.com","phone":null,"matters":["\u003cp\u003eA Better Choice Lock \u0026amp; Key LLC v.\u0026nbsp;\u003cstrong\u003eGoogle Inc.\u003c/strong\u003e\u0026nbsp;et al (DC Cir., filed 2016) (Lead counsel for defendant in Lanham Act, antitrust class action case with CDA Section 230 defense motion to dismiss granted and affirmed on appeal in precedential decision).\u003c/p\u003e","\u003cp\u003eBaldino\u0026rsquo;s Lock \u0026amp; Key Inc. v.\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGoogle Inc.\u003c/strong\u003e\u0026nbsp;et al (EDVA and 4th Cir., filed 2014) (Lead counsel for defendant securing CDA Section 230 defense on motion to dismiss in case involving Lanham Act and RICO claims).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eValerus Field Solutions LP\u003c/strong\u003e\u0026nbsp;v. Valerus Specialty Chemicals (SDTX, filed 2015) (Lead counsel for plaintiff in trademark infringement action, securing settlement prior to preliminary injunction motion).\u003c/p\u003e","\u003cp\u003eOn Site Energy Co. v.\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eMTU Onsite Energy\u003c/strong\u003e\u0026nbsp;(EDNY, filed 2010; jury trial August 2012) (Lead counsel in trademark infringement action challenging the use of the term ON SITE ENERGY in connection with power generators, securing jury verdict for the defense).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eSpanx, Inc.\u003c/strong\u003e\u0026nbsp;v. Times Three Clothiers d/b/a Yummie Tummie (NDGA, SDNY, filed 2013) (Lead counsel in design patent infringement declaratory judgment action and related design patent and utility patent infringement action, securing decision invalidating two patents with case resolved and dismissed thereafter).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eFritz Hansen A/S\u003c/strong\u003e\u0026nbsp;v. Restoration Hardware (SDNY, filed 2013) (Lead counsel in trademark and trade dress infringement action involving copies of chair designs, securing resolution).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc\u003c/strong\u003e. v. PRL Holdings (SDNY 2012) (Lead counsel in appeal of TTAB decision involving marks RLX RALPH LAUREN and RALPH LAUREN RLX, securing resolution prior to trial). Prior cases include:\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Capetown Diamond Corp. et al (N.D. Georgia 2003-2007) (Lead counsel in the latest of a series of cases establishing that genuine Rolex watches altered with non-genuine integral parts such as diamond bezels and bracelets are counterfeit);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Town \u0026amp; Country Jewelers (2005);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. JBJ Distributors, Inc. (5th Cir. July 29, 2003) (per curiam);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Zeotec Diamonds, Inc., 2003 U.S. Dist. LEXIS 5595 (C.D. Cal., Mar. 7, 2003) (Lead counsel);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Michel Co., 179 F.3d 704 (9th Cir. 1999);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Meece, 158 F.3d 816 (5th Cir. 1998).\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":6,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":7,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":8,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":9,"source":"smartTags"},{"id":1203,"guid":"1203.smart_tags","index":10,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":11,"source":"smartTags"},{"id":109,"guid":"109.capabilities","index":12,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":13,"source":"capabilities"},{"id":1233,"guid":"1233.smart_tags","index":14,"source":"smartTags"}],"is_active":true,"last_name":"McCarthy","nick_name":"Katie","clerkships":[],"first_name":"Kathleen","title_rank":9999,"updated_by":101,"law_schools":[{"id":485,"meta":{"degree":"J.D.","honors":"Harlan Fiske Stone Scholar","is_law_school":1,"graduation_date":"1986-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"E.","name_suffix":"","recognitions":[{"title":"Named as a recommended lawyer for Trademarks: Non-Contentious and Tradmarks: Litigation","detail":"Legal 500, 2022"},{"title":"Named for Trademark Law","detail":"Best Lawyers, 2023"},{"title":"Named a Trademark Star nationwide and in New York","detail":"Managing Intellectual Property, 2022"},{"title":"Ranked for Trademark Law nationwide and in New York","detail":"World Trademark Review 1000"},{"title":"Named to Managing Intellectual Property’s Global Top 250 Women in IP","detail":"Managing Intellectual Property, 2020"}],"linked_in_url":"https://www.linkedin.com/in/kathleenekatiemccarthy/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKatie McCarthy focuses on trademark, copyright, design, advertising and internet law. As a partner in our Intellectual Property, Patent, Trademark and Copyright Litigation practice, Katie represents clients in a wide array of industries including consumer products, pharmaceuticals, retail, internet services, sports and entertainment, cosmetics, and food and beverages. Katie appears on behalf of clients in federal court and before the U.S. Patent and Trademark Office's Trademark Trial and Appeal Board. Katie also develops domestic and international protection and enforcement programs.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDuring her more than 30 years of experience, Katie has first-chaired numerous trials and preliminary injunction hearings. Katie actively polices online infringement and scams for several clients. In addition to litigation and contested matters, Katie directs international and domestic trademark clearance and prosecution programs, manages domain name disputes and acquisitions, and develops social media and other intellectual property-related policies.\u003c/p\u003e\n\u003cp\u003eKatie also counsels clients on a broad range of IP-related matters, helping to find creative and practical solutions to legal challenges, and developing legal strategies and policies that advance their business goals.\u003c/p\u003e\n\u003cp\u003eKatie has served on the Board of the New York Intellectual Property Law Association for years, recently finishing a term as President during which she organized and moderated a forum of key discussion leaders debating online platform liability. Katie served as Editor-in-Chief of the International Trademark Association peer-reviewed scholarly journal,\u0026nbsp;\u003cem\u003eThe Trademark Reporter\u003c/em\u003e, having\u003cem\u003e\u0026nbsp;\u003c/em\u003eserved on the committee soliciting and editing articles for the journal for more than 20 years. Katie\u0026rsquo;s article, \u0026ldquo;Free Ride or Free Speech: Predicting Results and Providing Advice for Trademark Disputes Involving Parody\u0026rdquo; won INTA\u0026rsquo;s 2020 Ladas Memorial Award for best paper in the professional category. Katie has presented at and co-chaired PLI's IP Enforcement Update program annually since 2011 and frequently writes and speaks for PLI, INTA, NYIPLA and other organizations on trademark, copyright and false advertising topics.\u0026nbsp; Katie is the author of PLI\u0026rsquo;s one volume treatise, \u0026ldquo;Kane on Trademark Law: A Practitioner\u0026rsquo;s Guide.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003eKatie has been recognized in the 2012\u0026ndash;2016 editions of\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;for her trademark work.\u003c/p\u003e","matters":["\u003cp\u003eA Better Choice Lock \u0026amp; Key LLC v.\u0026nbsp;\u003cstrong\u003eGoogle Inc.\u003c/strong\u003e\u0026nbsp;et al (DC Cir., filed 2016) (Lead counsel for defendant in Lanham Act, antitrust class action case with CDA Section 230 defense motion to dismiss granted and affirmed on appeal in precedential decision).\u003c/p\u003e","\u003cp\u003eBaldino\u0026rsquo;s Lock \u0026amp; Key Inc. v.\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGoogle Inc.\u003c/strong\u003e\u0026nbsp;et al (EDVA and 4th Cir., filed 2014) (Lead counsel for defendant securing CDA Section 230 defense on motion to dismiss in case involving Lanham Act and RICO claims).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eValerus Field Solutions LP\u003c/strong\u003e\u0026nbsp;v. Valerus Specialty Chemicals (SDTX, filed 2015) (Lead counsel for plaintiff in trademark infringement action, securing settlement prior to preliminary injunction motion).\u003c/p\u003e","\u003cp\u003eOn Site Energy Co. v.\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eMTU Onsite Energy\u003c/strong\u003e\u0026nbsp;(EDNY, filed 2010; jury trial August 2012) (Lead counsel in trademark infringement action challenging the use of the term ON SITE ENERGY in connection with power generators, securing jury verdict for the defense).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eSpanx, Inc.\u003c/strong\u003e\u0026nbsp;v. Times Three Clothiers d/b/a Yummie Tummie (NDGA, SDNY, filed 2013) (Lead counsel in design patent infringement declaratory judgment action and related design patent and utility patent infringement action, securing decision invalidating two patents with case resolved and dismissed thereafter).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eFritz Hansen A/S\u003c/strong\u003e\u0026nbsp;v. Restoration Hardware (SDNY, filed 2013) (Lead counsel in trademark and trade dress infringement action involving copies of chair designs, securing resolution).\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc\u003c/strong\u003e. v. PRL Holdings (SDNY 2012) (Lead counsel in appeal of TTAB decision involving marks RLX RALPH LAUREN and RALPH LAUREN RLX, securing resolution prior to trial). Prior cases include:\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Capetown Diamond Corp. et al (N.D. Georgia 2003-2007) (Lead counsel in the latest of a series of cases establishing that genuine Rolex watches altered with non-genuine integral parts such as diamond bezels and bracelets are counterfeit);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Town \u0026amp; Country Jewelers (2005);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. JBJ Distributors, Inc. (5th Cir. July 29, 2003) (per curiam);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Zeotec Diamonds, Inc., 2003 U.S. Dist. LEXIS 5595 (C.D. Cal., Mar. 7, 2003) (Lead counsel);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Michel Co., 179 F.3d 704 (9th Cir. 1999);\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eRolex Watch U.S.A., Inc.\u003c/strong\u003e\u0026nbsp;v. Meece, 158 F.3d 816 (5th Cir. 1998).\u003c/p\u003e"],"recognitions":[{"title":"Named as a recommended lawyer for Trademarks: Non-Contentious and Tradmarks: Litigation","detail":"Legal 500, 2022"},{"title":"Named for Trademark Law","detail":"Best Lawyers, 2023"},{"title":"Named a Trademark Star nationwide and in New York","detail":"Managing Intellectual Property, 2022"},{"title":"Ranked for Trademark Law nationwide and in New York","detail":"World Trademark Review 1000"},{"title":"Named to Managing Intellectual Property’s Global Top 250 Women in IP","detail":"Managing Intellectual Property, 2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4266},{"id":4266}]},"capability_group_id":3},"created_at":"2025-09-02T04:50:27.000Z","updated_at":"2025-09-02T04:50:27.000Z","searchable_text":"McCarthy{{ FIELD }}{:title=\u0026gt;\"Named as a recommended lawyer for Trademarks: Non-Contentious and Tradmarks: Litigation\", :detail=\u0026gt;\"Legal 500, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Named for Trademark Law\", :detail=\u0026gt;\"Best Lawyers, 2023\"}{{ FIELD }}{:title=\u0026gt;\"Named a Trademark Star nationwide and in New York\", :detail=\u0026gt;\"Managing Intellectual Property, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked for Trademark Law nationwide and in New York\", :detail=\u0026gt;\"World Trademark Review 1000\"}{{ FIELD }}{:title=\u0026gt;\"Named to Managing Intellectual Property’s Global Top 250 Women in IP\", :detail=\u0026gt;\"Managing Intellectual Property, 2020\"}{{ FIELD }}A Better Choice Lock \u0026amp; Key LLC v. Google Inc. et al (DC Cir., filed 2016) (Lead counsel for defendant in Lanham Act, antitrust class action case with CDA Section 230 defense motion to dismiss granted and affirmed on appeal in precedential decision).{{ FIELD }}Baldino’s Lock \u0026amp; Key Inc. v. Google Inc. et al (EDVA and 4th Cir., filed 2014) (Lead counsel for defendant securing CDA Section 230 defense on motion to dismiss in case involving Lanham Act and RICO claims).{{ FIELD }}Valerus Field Solutions LP v. Valerus Specialty Chemicals (SDTX, filed 2015) (Lead counsel for plaintiff in trademark infringement action, securing settlement prior to preliminary injunction motion).{{ FIELD }}On Site Energy Co. v. MTU Onsite Energy (EDNY, filed 2010; jury trial August 2012) (Lead counsel in trademark infringement action challenging the use of the term ON SITE ENERGY in connection with power generators, securing jury verdict for the defense).{{ FIELD }}Spanx, Inc. v. Times Three Clothiers d/b/a Yummie Tummie (NDGA, SDNY, filed 2013) (Lead counsel in design patent infringement declaratory judgment action and related design patent and utility patent infringement action, securing decision invalidating two patents with case resolved and dismissed thereafter).{{ FIELD }}Fritz Hansen A/S v. Restoration Hardware (SDNY, filed 2013) (Lead counsel in trademark and trade dress infringement action involving copies of chair designs, securing resolution).{{ FIELD }}Rolex Watch U.S.A., Inc. v. PRL Holdings (SDNY 2012) (Lead counsel in appeal of TTAB decision involving marks RLX RALPH LAUREN and RALPH LAUREN RLX, securing resolution prior to trial). Prior cases include: Rolex Watch U.S.A., Inc. v. Capetown Diamond Corp. et al (N.D. Georgia 2003-2007) (Lead counsel in the latest of a series of cases establishing that genuine Rolex watches altered with non-genuine integral parts such as diamond bezels and bracelets are counterfeit);{{ FIELD }}Rolex Watch U.S.A., Inc. v. Town \u0026amp; Country Jewelers (2005);{{ FIELD }}Rolex Watch U.S.A., Inc. v. JBJ Distributors, Inc. (5th Cir. July 29, 2003) (per curiam);{{ FIELD }}Rolex Watch U.S.A., Inc. v. Zeotec Diamonds, Inc., 2003 U.S. Dist. LEXIS 5595 (C.D. Cal., Mar. 7, 2003) (Lead counsel);{{ FIELD }}Rolex Watch U.S.A., Inc. v. Michel Co., 179 F.3d 704 (9th Cir. 1999);{{ FIELD }}Rolex Watch U.S.A., Inc. v. Meece, 158 F.3d 816 (5th Cir. 1998).{{ FIELD }}Katie McCarthy focuses on trademark, copyright, design, advertising and internet law. As a partner in our Intellectual Property, Patent, Trademark and Copyright Litigation practice, Katie represents clients in a wide array of industries including consumer products, pharmaceuticals, retail, internet services, sports and entertainment, cosmetics, and food and beverages. Katie appears on behalf of clients in federal court and before the U.S. Patent and Trademark Office's Trademark Trial and Appeal Board. Katie also develops domestic and international protection and enforcement programs.\nDuring her more than 30 years of experience, Katie has first-chaired numerous trials and preliminary injunction hearings. Katie actively polices online infringement and scams for several clients. In addition to litigation and contested matters, Katie directs international and domestic trademark clearance and prosecution programs, manages domain name disputes and acquisitions, and develops social media and other intellectual property-related policies.\nKatie also counsels clients on a broad range of IP-related matters, helping to find creative and practical solutions to legal challenges, and developing legal strategies and policies that advance their business goals.\nKatie has served on the Board of the New York Intellectual Property Law Association for years, recently finishing a term as President during which she organized and moderated a forum of key discussion leaders debating online platform liability. Katie served as Editor-in-Chief of the International Trademark Association peer-reviewed scholarly journal, The Trademark Reporter, having served on the committee soliciting and editing articles for the journal for more than 20 years. Katie’s article, “Free Ride or Free Speech: Predicting Results and Providing Advice for Trademark Disputes Involving Parody” won INTA’s 2020 Ladas Memorial Award for best paper in the professional category. Katie has presented at and co-chaired PLI's IP Enforcement Update program annually since 2011 and frequently writes and speaks for PLI, INTA, NYIPLA and other organizations on trademark, copyright and false advertising topics.  Katie is the author of PLI’s one volume treatise, “Kane on Trademark Law: A Practitioner’s Guide.”\nKatie has been recognized in the 2012–2016 editions of Legal 500 for her trademark work. Partner Named as a recommended lawyer for Trademarks: Non-Contentious and Tradmarks: Litigation Legal 500, 2022 Named for Trademark Law Best Lawyers, 2023 Named a Trademark Star nationwide and in New York Managing Intellectual Property, 2022 Ranked for Trademark Law nationwide and in New York World Trademark Review 1000 Named to Managing Intellectual Property’s Global Top 250 Women in IP Managing Intellectual Property, 2020 College of the Holy Cross  Columbia University Columbia University School of Law U.S. Court of Appeals for the Federal Circuit Supreme Court of the United States U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York New York New York A Better Choice Lock \u0026amp; Key LLC v. Google Inc. et al (DC Cir., filed 2016) (Lead counsel for defendant in Lanham Act, antitrust class action case with CDA Section 230 defense motion to dismiss granted and affirmed on appeal in precedential decision). Baldino’s Lock \u0026amp; Key Inc. v. Google Inc. et al (EDVA and 4th Cir., filed 2014) (Lead counsel for defendant securing CDA Section 230 defense on motion to dismiss in case involving Lanham Act and RICO claims). Valerus Field Solutions LP v. Valerus Specialty Chemicals (SDTX, filed 2015) (Lead counsel for plaintiff in trademark infringement action, securing settlement prior to preliminary injunction motion). On Site Energy Co. v. MTU Onsite Energy (EDNY, filed 2010; jury trial August 2012) (Lead counsel in trademark infringement action challenging the use of the term ON SITE ENERGY in connection with power generators, securing jury verdict for the defense). Spanx, Inc. v. Times Three Clothiers d/b/a Yummie Tummie (NDGA, SDNY, filed 2013) (Lead counsel in design patent infringement declaratory judgment action and related design patent and utility patent infringement action, securing decision invalidating two patents with case resolved and dismissed thereafter). Fritz Hansen A/S v. Restoration Hardware (SDNY, filed 2013) (Lead counsel in trademark and trade dress infringement action involving copies of chair designs, securing resolution). Rolex Watch U.S.A., Inc. v. PRL Holdings (SDNY 2012) (Lead counsel in appeal of TTAB decision involving marks RLX RALPH LAUREN and RALPH LAUREN RLX, securing resolution prior to trial). Prior cases include: Rolex Watch U.S.A., Inc. v. Capetown Diamond Corp. et al (N.D. Georgia 2003-2007) (Lead counsel in the latest of a series of cases establishing that genuine Rolex watches altered with non-genuine integral parts such as diamond bezels and bracelets are counterfeit); Rolex Watch U.S.A., Inc. v. Town \u0026amp; Country Jewelers (2005); Rolex Watch U.S.A., Inc. v. JBJ Distributors, Inc. (5th Cir. July 29, 2003) (per curiam); Rolex Watch U.S.A., Inc. v. Zeotec Diamonds, Inc., 2003 U.S. Dist. LEXIS 5595 (C.D. Cal., Mar. 7, 2003) (Lead counsel); Rolex Watch U.S.A., Inc. v. Michel Co., 179 F.3d 704 (9th Cir. 1999); Rolex Watch U.S.A., Inc. v. Meece, 158 F.3d 816 (5th Cir. 1998).","searchable_name":"Kathleen E. McCarthy (Katie)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442801,"version":1,"owner_type":"Person","owner_id":5630,"payload":{"bio":"\u003cp\u003eGenevi\u0026egrave;ve Michaux is a Belgian- and French-qualified lawyer in the FDA and Life Sciences practice.\u003c/p\u003e\n\u003cp\u003eRecognized as one of the most highly regarded European Union (EU) life sciences regulatory specialists, Genevi\u0026egrave;ve assists companies on a wide variety of issues under EU and national (French and Belgian) food and drug laws and regulations, with an emphasis on regulatory matters involving drugs, biologics, medical devices, cosmetics and food. She also advises life sciences clients on significant policy developments in the EU and assists with broader European and global projects.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve\u0026rsquo;s work spans matters ranging from regulatory status of borderline products, authorization procedures, life cycle management, clinical trials and investigations, labeling, advertising and promotions for all categories of products, and issues raised by specific categories of medicinal products, such as pediatric, orphan or advance therapy medicinal products. She has advised on various issues arising out of the EU Pediatric Regulation, EU Orphan Regulation, SPC and SPC extension, and ATMPs at the European and national level. She also counsels startups on establishing themselves in the EU as well as complying with advertising and scientific information rules, regulatory and legal guidance.\u003c/p\u003e\n\u003cp\u003eShe assists life sciences companies in forming patient/compassionate use programs in Europe, negotiating and drafting consortia related agreements, reviewing clinical trial and clinical investigation agreements, interacting with healthcare professionals in connection with advertising and promotion efforts, and product classification matters such as borderlines between drug, medical device, cosmetic and food supplement, and assistance with local authorities.\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve has extensive litigation experience in life science matters, including product liability and advertising and promotional activities.\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve is recognized as one of the \"Most Highly Regarded Individuals\" in the regulatory field (Who's Who Legal, Life Sciences 2016). In the same publication, her clients reported that she has an \"unsurpassed knowledge of legal areas,\" as well as being \"extremely dedicated to the case and the client.\" She has published numerous articles on food and drug law and speaks at legal and regulatory conferences on pharmaceuticals and medical devices.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eOctober 2019, \u0026ldquo;Are the paediatric rewards adapted? \u0026ldquo;, Clinical Research in Paediatric Psychopharmacology, P. Auby, Elsevier, 2020\u003c/li\u003e\n\u003cli\u003eMay 30, 2019, \u0026ldquo;The regulation of advanced therapy medicinal products\u0026rdquo;\u0026nbsp;\u003cem\u003eLexisNexis.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eApril 2017, \u0026ldquo;Pediatric Regulation \u0026ndash; A Better application for more efficient incentives,\u0026rdquo;\u0026nbsp;\u003cem\u003eThe European Files, Medicines of the Future.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eSeptember 2016, \u0026ldquo;Should Anthroposophic Medicinal Products Be Regulated in Europe?\u0026rdquo;\u0026nbsp;\u003cem\u003eJournal of European Health Law\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eJune 8, 2016, \u0026ldquo;Demonstrating Significant Benefit For Orphan Medicines \u0026ndash; Is It Time For A Drastic Change?\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;EU Pediatric Rewards \u0026ndash; More Questions than Answers,\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eFebruary 2016, \u0026ldquo;The Need For Clarification On Post-Market Requirements For Pediatric Medicines,\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSpeaking Engagements\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eSeptember 9, 2019, \u0026ldquo;\u003cem\u003eSummary of Key EUCJ Decisions\u003c/em\u003e,\u0026rdquo; European Pharmaceutical Law Academy.\u003c/li\u003e\n\u003cli\u003eJune 5, 2019, \u0026ldquo;Approval Process for Drugs and Medical Devices,\u0026rdquo; European Healthcare Industry Training: Compliance Certificate Program.\u003c/li\u003e\n\u003cli\u003eSeptember 10, 2018, \u0026ldquo;ATMP Regulatory Framework\u003cem\u003e,\u0026rdquo;\u0026nbsp;\u003c/em\u003eEuropean Pharmaceutical Law Academy, Cambridge, UK.\u003c/li\u003e\n\u003cli\u003eJune 2018, \u0026ldquo;Approval Process for Drugs and Medical Devices,\u0026rdquo; European Healthcare Industry Training: Compliance Certificate Program.\u003c/li\u003e\n\u003cli\u003eMay 15, 2018, \u0026ldquo;International Labeling Regulatory Requirements,\u0026rdquo; co-presented with Hank Bullock, 8th Annual Medical Device \u0026amp; Diagnostic Labeling Conference in Chicago, IL.\u003c/li\u003e\n\u003cli\u003eMarch 21, 2018, Workshop on Pediatric Regulation and SMi in London.\u003c/li\u003e\n\u003cli\u003eMarch 2018, ATMPs \u0026ndash; Challenges and Promises, ERA, EU Pharmaceutical Law.\u003c/li\u003e\n\u003cli\u003eNovember 2017, Borderline issues, Congr\u0026egrave;s Parfums \u0026amp; Cosm\u0026eacute;tiques, Enjeux r\u0026eacute;glementaires, Chartres.\u003c/li\u003e\n\u003cli\u003eSeptember 2017, SPCs and Regulatory Concepts, 9th SPC Forum, Riga.\u003c/li\u003e\n\u003cli\u003eSeptember 2017, Pediatric Regulation, KNet365, Pharmaceutical Law Academy, Cambridge (UK).\u003c/li\u003e\n\u003cli\u003eJune 2017, Regulatory protections, KNet365, Life Science IP Minds 2017, London.\u0026nbsp;\u003c/li\u003e\n\u003cli\u003eMarch 2017, Pediatric rewards, SMI, Pediatric Clinical Trials, London.\u003c/li\u003e\n\u003cli\u003eMarch 2017, Revision of the Pediatric Regulation, DIA, 29th Annual EuroMeeting, Glasgow.\u003c/li\u003e\n\u003cli\u003eNovember 2016, SPCs and Regulatory Authorizations, 7th SPC forum in Paris, France.\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;Protection for Mature Product,\u0026rdquo; DIA, 28th Annual EuroMeeting, Hamburg.\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;Interactions between regulatory and intellectual property, product liability and data privacy,\u0026rdquo; DIA, 28th Annual EuroMeeting in Hamburg.\u003c/li\u003e\n\u003c/ul\u003e","slug":"genevieve-michaux","email":"gmichaux@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":5,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":6,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":7,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":8,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":9,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":10,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":11,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":12,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":13,"source":"capabilities"}],"is_active":true,"last_name":"Michaux","nick_name":"Geneviève","clerkships":[],"first_name":"Geneviève","title_rank":9999,"updated_by":101,"law_schools":[{"id":824,"meta":{"degree":"Law Degree","honors":null,"is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":0,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ranked in the Regulatory Practice","detail":"Best Lawyers Belgium, 2022"},{"title":"Global Elite Thought Leaders EMEA","detail":"WWL Life Sciences Report, 2022"},{"title":"Who's Who Legal, Life Sciences","detail":"2011–2022"},{"title":"Excellent in Healthcare, pharmaceuticals \u0026 biotech","detail":"Leadersleague Décideurs Belgium Life Sciences guide, 2021"},{"title":"Legal 500, EU Regulatory and EU Pharmaceuticals and Biotechnology","detail":"2012"},{"title":"PLC Which Lawyer?, Life Sciences","detail":"Regulatory, EU, 2012"},{"title":"de Harzen Prize (ULB) for excellence in Case Resolution over all five years of study","detail":"1988"}],"linked_in_url":"https://www.linkedin.com/in/geneviève-michaux-165829/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eGenevi\u0026egrave;ve Michaux is a Belgian- and French-qualified lawyer in the FDA and Life Sciences practice.\u003c/p\u003e\n\u003cp\u003eRecognized as one of the most highly regarded European Union (EU) life sciences regulatory specialists, Genevi\u0026egrave;ve assists companies on a wide variety of issues under EU and national (French and Belgian) food and drug laws and regulations, with an emphasis on regulatory matters involving drugs, biologics, medical devices, cosmetics and food. She also advises life sciences clients on significant policy developments in the EU and assists with broader European and global projects.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve\u0026rsquo;s work spans matters ranging from regulatory status of borderline products, authorization procedures, life cycle management, clinical trials and investigations, labeling, advertising and promotions for all categories of products, and issues raised by specific categories of medicinal products, such as pediatric, orphan or advance therapy medicinal products. She has advised on various issues arising out of the EU Pediatric Regulation, EU Orphan Regulation, SPC and SPC extension, and ATMPs at the European and national level. She also counsels startups on establishing themselves in the EU as well as complying with advertising and scientific information rules, regulatory and legal guidance.\u003c/p\u003e\n\u003cp\u003eShe assists life sciences companies in forming patient/compassionate use programs in Europe, negotiating and drafting consortia related agreements, reviewing clinical trial and clinical investigation agreements, interacting with healthcare professionals in connection with advertising and promotion efforts, and product classification matters such as borderlines between drug, medical device, cosmetic and food supplement, and assistance with local authorities.\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve has extensive litigation experience in life science matters, including product liability and advertising and promotional activities.\u003c/p\u003e\n\u003cp\u003eGenevi\u0026egrave;ve is recognized as one of the \"Most Highly Regarded Individuals\" in the regulatory field (Who's Who Legal, Life Sciences 2016). In the same publication, her clients reported that she has an \"unsurpassed knowledge of legal areas,\" as well as being \"extremely dedicated to the case and the client.\" She has published numerous articles on food and drug law and speaks at legal and regulatory conferences on pharmaceuticals and medical devices.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eOctober 2019, \u0026ldquo;Are the paediatric rewards adapted? \u0026ldquo;, Clinical Research in Paediatric Psychopharmacology, P. Auby, Elsevier, 2020\u003c/li\u003e\n\u003cli\u003eMay 30, 2019, \u0026ldquo;The regulation of advanced therapy medicinal products\u0026rdquo;\u0026nbsp;\u003cem\u003eLexisNexis.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eApril 2017, \u0026ldquo;Pediatric Regulation \u0026ndash; A Better application for more efficient incentives,\u0026rdquo;\u0026nbsp;\u003cem\u003eThe European Files, Medicines of the Future.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eSeptember 2016, \u0026ldquo;Should Anthroposophic Medicinal Products Be Regulated in Europe?\u0026rdquo;\u0026nbsp;\u003cem\u003eJournal of European Health Law\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eJune 8, 2016, \u0026ldquo;Demonstrating Significant Benefit For Orphan Medicines \u0026ndash; Is It Time For A Drastic Change?\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;EU Pediatric Rewards \u0026ndash; More Questions than Answers,\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003cli\u003eFebruary 2016, \u0026ldquo;The Need For Clarification On Post-Market Requirements For Pediatric Medicines,\u0026rdquo;\u0026nbsp;\u003cem\u003eScrip Regulatory Affairs.\u003c/em\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSpeaking Engagements\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003eSeptember 9, 2019, \u0026ldquo;\u003cem\u003eSummary of Key EUCJ Decisions\u003c/em\u003e,\u0026rdquo; European Pharmaceutical Law Academy.\u003c/li\u003e\n\u003cli\u003eJune 5, 2019, \u0026ldquo;Approval Process for Drugs and Medical Devices,\u0026rdquo; European Healthcare Industry Training: Compliance Certificate Program.\u003c/li\u003e\n\u003cli\u003eSeptember 10, 2018, \u0026ldquo;ATMP Regulatory Framework\u003cem\u003e,\u0026rdquo;\u0026nbsp;\u003c/em\u003eEuropean Pharmaceutical Law Academy, Cambridge, UK.\u003c/li\u003e\n\u003cli\u003eJune 2018, \u0026ldquo;Approval Process for Drugs and Medical Devices,\u0026rdquo; European Healthcare Industry Training: Compliance Certificate Program.\u003c/li\u003e\n\u003cli\u003eMay 15, 2018, \u0026ldquo;International Labeling Regulatory Requirements,\u0026rdquo; co-presented with Hank Bullock, 8th Annual Medical Device \u0026amp; Diagnostic Labeling Conference in Chicago, IL.\u003c/li\u003e\n\u003cli\u003eMarch 21, 2018, Workshop on Pediatric Regulation and SMi in London.\u003c/li\u003e\n\u003cli\u003eMarch 2018, ATMPs \u0026ndash; Challenges and Promises, ERA, EU Pharmaceutical Law.\u003c/li\u003e\n\u003cli\u003eNovember 2017, Borderline issues, Congr\u0026egrave;s Parfums \u0026amp; Cosm\u0026eacute;tiques, Enjeux r\u0026eacute;glementaires, Chartres.\u003c/li\u003e\n\u003cli\u003eSeptember 2017, SPCs and Regulatory Concepts, 9th SPC Forum, Riga.\u003c/li\u003e\n\u003cli\u003eSeptember 2017, Pediatric Regulation, KNet365, Pharmaceutical Law Academy, Cambridge (UK).\u003c/li\u003e\n\u003cli\u003eJune 2017, Regulatory protections, KNet365, Life Science IP Minds 2017, London.\u0026nbsp;\u003c/li\u003e\n\u003cli\u003eMarch 2017, Pediatric rewards, SMI, Pediatric Clinical Trials, London.\u003c/li\u003e\n\u003cli\u003eMarch 2017, Revision of the Pediatric Regulation, DIA, 29th Annual EuroMeeting, Glasgow.\u003c/li\u003e\n\u003cli\u003eNovember 2016, SPCs and Regulatory Authorizations, 7th SPC forum in Paris, France.\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;Protection for Mature Product,\u0026rdquo; DIA, 28th Annual EuroMeeting, Hamburg.\u003c/li\u003e\n\u003cli\u003eApril 2016, \u0026ldquo;Interactions between regulatory and intellectual property, product liability and data privacy,\u0026rdquo; DIA, 28th Annual EuroMeeting in Hamburg.\u003c/li\u003e\n\u003c/ul\u003e","recognitions":[{"title":"Ranked in the Regulatory Practice","detail":"Best Lawyers Belgium, 2022"},{"title":"Global Elite Thought Leaders EMEA","detail":"WWL Life Sciences Report, 2022"},{"title":"Who's Who Legal, Life Sciences","detail":"2011–2022"},{"title":"Excellent in Healthcare, pharmaceuticals \u0026 biotech","detail":"Leadersleague Décideurs Belgium Life Sciences guide, 2021"},{"title":"Legal 500, EU Regulatory and EU Pharmaceuticals and Biotechnology","detail":"2012"},{"title":"PLC Which Lawyer?, Life Sciences","detail":"Regulatory, EU, 2012"},{"title":"de Harzen Prize (ULB) for excellence in Case Resolution over all five years of study","detail":"1988"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8884}]},"capability_group_id":2},"created_at":"2025-11-13T04:57:39.000Z","updated_at":"2025-11-13T04:57:39.000Z","searchable_text":"Michaux{{ FIELD }}{:title=\u0026gt;\"Ranked in the Regulatory Practice\", :detail=\u0026gt;\"Best Lawyers Belgium, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Global Elite Thought Leaders EMEA\", :detail=\u0026gt;\"WWL Life Sciences Report, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Who's Who Legal, Life Sciences\", :detail=\u0026gt;\"2011–2022\"}{{ FIELD }}{:title=\u0026gt;\"Excellent in Healthcare, pharmaceuticals \u0026amp; biotech\", :detail=\u0026gt;\"Leadersleague Décideurs Belgium Life Sciences guide, 2021\"}{{ FIELD }}{:title=\u0026gt;\"Legal 500, EU Regulatory and EU Pharmaceuticals and Biotechnology\", :detail=\u0026gt;\"2012\"}{{ FIELD }}{:title=\u0026gt;\"PLC Which Lawyer?, Life Sciences\", :detail=\u0026gt;\"Regulatory, EU, 2012\"}{{ FIELD }}{:title=\u0026gt;\"de Harzen Prize (ULB) for excellence in Case Resolution over all five years of study\", :detail=\u0026gt;\"1988\"}{{ FIELD }}Geneviève Michaux is a Belgian- and French-qualified lawyer in the FDA and Life Sciences practice.\nRecognized as one of the most highly regarded European Union (EU) life sciences regulatory specialists, Geneviève assists companies on a wide variety of issues under EU and national (French and Belgian) food and drug laws and regulations, with an emphasis on regulatory matters involving drugs, biologics, medical devices, cosmetics and food. She also advises life sciences clients on significant policy developments in the EU and assists with broader European and global projects.\nGeneviève’s work spans matters ranging from regulatory status of borderline products, authorization procedures, life cycle management, clinical trials and investigations, labeling, advertising and promotions for all categories of products, and issues raised by specific categories of medicinal products, such as pediatric, orphan or advance therapy medicinal products. She has advised on various issues arising out of the EU Pediatric Regulation, EU Orphan Regulation, SPC and SPC extension, and ATMPs at the European and national level. She also counsels startups on establishing themselves in the EU as well as complying with advertising and scientific information rules, regulatory and legal guidance.\nShe assists life sciences companies in forming patient/compassionate use programs in Europe, negotiating and drafting consortia related agreements, reviewing clinical trial and clinical investigation agreements, interacting with healthcare professionals in connection with advertising and promotion efforts, and product classification matters such as borderlines between drug, medical device, cosmetic and food supplement, and assistance with local authorities.\nGeneviève has extensive litigation experience in life science matters, including product liability and advertising and promotional activities.\nGeneviève is recognized as one of the \"Most Highly Regarded Individuals\" in the regulatory field (Who's Who Legal, Life Sciences 2016). In the same publication, her clients reported that she has an \"unsurpassed knowledge of legal areas,\" as well as being \"extremely dedicated to the case and the client.\" She has published numerous articles on food and drug law and speaks at legal and regulatory conferences on pharmaceuticals and medical devices.\nPublications\n\nOctober 2019, “Are the paediatric rewards adapted? “, Clinical Research in Paediatric Psychopharmacology, P. Auby, Elsevier, 2020\nMay 30, 2019, “The regulation of advanced therapy medicinal products” LexisNexis.\nApril 2017, “Pediatric Regulation – A Better application for more efficient incentives,” The European Files, Medicines of the Future.\nSeptember 2016, “Should Anthroposophic Medicinal Products Be Regulated in Europe?” Journal of European Health Law\nJune 8, 2016, “Demonstrating Significant Benefit For Orphan Medicines – Is It Time For A Drastic Change?” Scrip Regulatory Affairs.\nApril 2016, “EU Pediatric Rewards – More Questions than Answers,” Scrip Regulatory Affairs.\nFebruary 2016, “The Need For Clarification On Post-Market Requirements For Pediatric Medicines,” Scrip Regulatory Affairs.\n\nSpeaking Engagements\n\nSeptember 9, 2019, “Summary of Key EUCJ Decisions,” European Pharmaceutical Law Academy.\nJune 5, 2019, “Approval Process for Drugs and Medical Devices,” European Healthcare Industry Training: Compliance Certificate Program.\nSeptember 10, 2018, “ATMP Regulatory Framework,” European Pharmaceutical Law Academy, Cambridge, UK.\nJune 2018, “Approval Process for Drugs and Medical Devices,” European Healthcare Industry Training: Compliance Certificate Program.\nMay 15, 2018, “International Labeling Regulatory Requirements,” co-presented with Hank Bullock, 8th Annual Medical Device \u0026amp; Diagnostic Labeling Conference in Chicago, IL.\nMarch 21, 2018, Workshop on Pediatric Regulation and SMi in London.\nMarch 2018, ATMPs – Challenges and Promises, ERA, EU Pharmaceutical Law.\nNovember 2017, Borderline issues, Congrès Parfums \u0026amp; Cosmétiques, Enjeux réglementaires, Chartres.\nSeptember 2017, SPCs and Regulatory Concepts, 9th SPC Forum, Riga.\nSeptember 2017, Pediatric Regulation, KNet365, Pharmaceutical Law Academy, Cambridge (UK).\nJune 2017, Regulatory protections, KNet365, Life Science IP Minds 2017, London. \nMarch 2017, Pediatric rewards, SMI, Pediatric Clinical Trials, London.\nMarch 2017, Revision of the Pediatric Regulation, DIA, 29th Annual EuroMeeting, Glasgow.\nNovember 2016, SPCs and Regulatory Authorizations, 7th SPC forum in Paris, France.\nApril 2016, “Protection for Mature Product,” DIA, 28th Annual EuroMeeting, Hamburg.\nApril 2016, “Interactions between regulatory and intellectual property, product liability and data privacy,” DIA, 28th Annual EuroMeeting in Hamburg.\n Partner Ranked in the Regulatory Practice Best Lawyers Belgium, 2022 Global Elite Thought Leaders EMEA WWL Life Sciences Report, 2022 Who's Who Legal, Life Sciences 2011–2022 Excellent in Healthcare, pharmaceuticals \u0026amp; biotech Leadersleague Décideurs Belgium Life Sciences guide, 2021 Legal 500, EU Regulatory and EU Pharmaceuticals and Biotechnology 2012 PLC Which Lawyer?, Life Sciences Regulatory, EU, 2012 de Harzen Prize (ULB) for excellence in Case Resolution over all five years of study 1988 Harvard University Harvard Law School Universite Libre de Bruxelles, Belgium  Paris Brussels Member of the editorial board of SCRIP Regulatory Affairs Mediator with the Brussels Business Mediation Center Member of the DIA Advisory Committee for Europe Middle East Africa Foreign Correspondent Member of the National Academy of Pharmacy (France)","searchable_name":"Geneviève Michaux","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":448720,"version":1,"owner_type":"Person","owner_id":5092,"payload":{"bio":"\u003cp\u003eTroy McMahan has more than 30 years of experience defending Fortune 500 companies in cases involving premises and products liability claims, toxic tort claims, maritime claims and business disputes involving the improper use of proprietary information. He serves as counsel for multiple corporations and organizations across a broad range of industries including Chevron, Texaco, and Dow.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTroy often acts as jointly retained counsel for multiple industry defendants and has years of experience in structuring and managing such joint defenses.\u003c/p\u003e\n\u003cp\u003eTroy has extensive experience litigating product and premises liability dockets throughout the U.S. including California. He specializes in toxic tort cases involving claims of contaminants exposure from the workplace or through consumer goods. Troy also has special expertise in product liability defense for automobile manufacturers in cases involving automotive design and manufacture. He has tried jury cases to verdict involving asbestos-containing brake products, and has\u0026nbsp;secured defense verdicts for automobile manufacturers in cases alleging that a defective ignition switch\u0026nbsp;caused a vehicle fire and subsequent property damage, as well as a case alleging violations of the California\u0026nbsp;Song Beverly Consumer Warranty Act.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTroy has received recognition as a top rated products liability attorney on numerous occasions by\u0026nbsp;\u003cem\u003eSuper Lawyers\u003c/em\u003e, and he has been invited to be a guest instructor for\u0026nbsp;a course entitled \"Depositions - Witness Preparation\"\u0026nbsp;at the University of California, Berkeley, School of Law (Feb. 2024).\u003c/p\u003e","slug":"troy-mcmahan","email":"tmcmahan@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eFood and Beverage\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented an\u0026nbsp;\u003cstrong\u003eegg producer\u003c/strong\u003e\u0026nbsp;in connection with commercial claims arising from a 2010 salmonella outbreak and recall (the largest egg salmonella outbreak in history) and related FDA investigation.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCounsel for\u0026nbsp;\u003cstrong\u003ecrude oil refiners\u0026nbsp;\u003c/strong\u003eand\u003cstrong\u003e\u0026nbsp;manufacturers of industrial commercial and consumer grade chemical products\u003c/strong\u003e\u0026nbsp;in personal injury and wrongful death cases involving cancer, systemic diseases and immune system dysfunction.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eMaritime\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003evessel owners and operators\u003c/strong\u003e\u0026nbsp;in matters involving wrongful death and personal injury cases filed by seaman, longshoreman and shipyard contractors under federal maritime law \u0026mdash; Jones Act, Longshoreman and Harbor Workers\u0026rsquo; Compensation Act and federal maritime common law.\u003c/p\u003e","\u003cp\u003eSecured summary judgment for a\u0026nbsp;\u003cstrong\u003eshipping client\u003c/strong\u003e\u0026nbsp;in a case of first impression \u0026mdash; whether federal maritime law imposes a duty upon a ship owner to protect offshore third parties from injuries occurring as a result of activities performed aboard ship. Specifically, plaintiff claimed exposure to toxins used aboard the vessel, and which his father \u0026mdash; an officer aboard the vessel \u0026mdash; allegedly brought home on his uniform.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAsbestos\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc.\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eTexaco Inc.\u003c/strong\u003e, and\u0026nbsp;\u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e\u0026nbsp;in trial asbestos product and premises liability dockets throughout the State of California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAutomotive\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSecured a defense verdict at trial on behalf of the\u0026nbsp;\u003cstrong\u003eFord Motor Company\u0026nbsp;\u003c/strong\u003eon insurance subrogation claim brought by an insurance company against Ford based on claims of a defective ignition switch.\u003c/p\u003e","\u003cp\u003eSecured summary judgment for\u0026nbsp;\u003cstrong\u003eFord Motor Company\u003c/strong\u003e\u0026nbsp;against plaintiff\u0026rsquo;s product liability claim based on allegations that a defective seatbelt caused plaintiff to sustain injuries during an automobile accident.\u003c/p\u003e","\u003cp\u003eSecured a defense judgment on behalf of a\u0026nbsp;\u003cstrong\u003eforeign gas tank manufacturer\u003c/strong\u003e\u0026nbsp;in a personal injury case brought by several plaintiffs who sustained personal injuries when their personal watercraft exploded causing several of the plaintiffs to claim brain damage, partial blindness and severe emotional distress.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGovernment Tort Liability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBay Area Rapid Transit District (BART)\u003c/strong\u003e\u0026nbsp;in various personal injury and property damage claims arising from construction activities occurring during the BART extension projects.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":17,"guid":"17.capabilities","index":0,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":1,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":2,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":3,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1256,"guid":"1256.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"McMahan","nick_name":"Troy","clerkships":[],"first_name":"Troy","title_rank":9999,"updated_by":196,"law_schools":[],"middle_name":"D.","name_suffix":"","recognitions":[{"title":"Selected to Super Lawyers (2006, 2010-2015, 2020)","detail":"Super Lawyers"}],"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eTroy McMahan has more than 30 years of experience defending Fortune 500 companies in cases involving premises and products liability claims, toxic tort claims, maritime claims and business disputes involving the improper use of proprietary information. He serves as counsel for multiple corporations and organizations across a broad range of industries including Chevron, Texaco, and Dow.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eTroy often acts as jointly retained counsel for multiple industry defendants and has years of experience in structuring and managing such joint defenses.\u003c/p\u003e\n\u003cp\u003eTroy has extensive experience litigating product and premises liability dockets throughout the U.S. including California. He specializes in toxic tort cases involving claims of contaminants exposure from the workplace or through consumer goods. Troy also has special expertise in product liability defense for automobile manufacturers in cases involving automotive design and manufacture. He has tried jury cases to verdict involving asbestos-containing brake products, and has\u0026nbsp;secured defense verdicts for automobile manufacturers in cases alleging that a defective ignition switch\u0026nbsp;caused a vehicle fire and subsequent property damage, as well as a case alleging violations of the California\u0026nbsp;Song Beverly Consumer Warranty Act.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eTroy has received recognition as a top rated products liability attorney on numerous occasions by\u0026nbsp;\u003cem\u003eSuper Lawyers\u003c/em\u003e, and he has been invited to be a guest instructor for\u0026nbsp;a course entitled \"Depositions - Witness Preparation\"\u0026nbsp;at the University of California, Berkeley, School of Law (Feb. 2024).\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eFood and Beverage\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented an\u0026nbsp;\u003cstrong\u003eegg producer\u003c/strong\u003e\u0026nbsp;in connection with commercial claims arising from a 2010 salmonella outbreak and recall (the largest egg salmonella outbreak in history) and related FDA investigation.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eToxic Tort\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCounsel for\u0026nbsp;\u003cstrong\u003ecrude oil refiners\u0026nbsp;\u003c/strong\u003eand\u003cstrong\u003e\u0026nbsp;manufacturers of industrial commercial and consumer grade chemical products\u003c/strong\u003e\u0026nbsp;in personal injury and wrongful death cases involving cancer, systemic diseases and immune system dysfunction.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eMaritime\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003evessel owners and operators\u003c/strong\u003e\u0026nbsp;in matters involving wrongful death and personal injury cases filed by seaman, longshoreman and shipyard contractors under federal maritime law \u0026mdash; Jones Act, Longshoreman and Harbor Workers\u0026rsquo; Compensation Act and federal maritime common law.\u003c/p\u003e","\u003cp\u003eSecured summary judgment for a\u0026nbsp;\u003cstrong\u003eshipping client\u003c/strong\u003e\u0026nbsp;in a case of first impression \u0026mdash; whether federal maritime law imposes a duty upon a ship owner to protect offshore third parties from injuries occurring as a result of activities performed aboard ship. Specifically, plaintiff claimed exposure to toxins used aboard the vessel, and which his father \u0026mdash; an officer aboard the vessel \u0026mdash; allegedly brought home on his uniform.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAsbestos\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eChevron U.S.A. Inc.\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eTexaco Inc.\u003c/strong\u003e, and\u0026nbsp;\u003cstrong\u003eThe Dow Chemical Company\u003c/strong\u003e\u0026nbsp;in trial asbestos product and premises liability dockets throughout the State of California.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eAutomotive\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSecured a defense verdict at trial on behalf of the\u0026nbsp;\u003cstrong\u003eFord Motor Company\u0026nbsp;\u003c/strong\u003eon insurance subrogation claim brought by an insurance company against Ford based on claims of a defective ignition switch.\u003c/p\u003e","\u003cp\u003eSecured summary judgment for\u0026nbsp;\u003cstrong\u003eFord Motor Company\u003c/strong\u003e\u0026nbsp;against plaintiff\u0026rsquo;s product liability claim based on allegations that a defective seatbelt caused plaintiff to sustain injuries during an automobile accident.\u003c/p\u003e","\u003cp\u003eSecured a defense judgment on behalf of a\u0026nbsp;\u003cstrong\u003eforeign gas tank manufacturer\u003c/strong\u003e\u0026nbsp;in a personal injury case brought by several plaintiffs who sustained personal injuries when their personal watercraft exploded causing several of the plaintiffs to claim brain damage, partial blindness and severe emotional distress.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGovernment Tort Liability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBay Area Rapid Transit District (BART)\u003c/strong\u003e\u0026nbsp;in various personal injury and property damage claims arising from construction activities occurring during the BART extension projects.\u003c/p\u003e"],"recognitions":[{"title":"Selected to Super Lawyers (2006, 2010-2015, 2020)","detail":"Super Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5912}]},"capability_group_id":3},"created_at":"2026-05-28T21:56:41.000Z","updated_at":"2026-05-28T21:56:41.000Z","searchable_text":"McMahan{{ FIELD }}{:title=\u0026gt;\"Selected to Super Lawyers (2006, 2010-2015, 2020)\", :detail=\u0026gt;\"Super Lawyers\"}{{ FIELD }}Food and Beverage\nRepresented an egg producer in connection with commercial claims arising from a 2010 salmonella outbreak and recall (the largest egg salmonella outbreak in history) and related FDA investigation.{{ FIELD }}Toxic Tort\nCounsel for crude oil refiners and manufacturers of industrial commercial and consumer grade chemical products in personal injury and wrongful death cases involving cancer, systemic diseases and immune system dysfunction.{{ FIELD }}Maritime\nRepresent vessel owners and operators in matters involving wrongful death and personal injury cases filed by seaman, longshoreman and shipyard contractors under federal maritime law — Jones Act, Longshoreman and Harbor Workers’ Compensation Act and federal maritime common law.{{ FIELD }}Secured summary judgment for a shipping client in a case of first impression — whether federal maritime law imposes a duty upon a ship owner to protect offshore third parties from injuries occurring as a result of activities performed aboard ship. Specifically, plaintiff claimed exposure to toxins used aboard the vessel, and which his father — an officer aboard the vessel — allegedly brought home on his uniform.{{ FIELD }}Asbestos\nRepresent Chevron U.S.A. Inc., Texaco Inc., and The Dow Chemical Company in trial asbestos product and premises liability dockets throughout the State of California.{{ FIELD }}Automotive\nSecured a defense verdict at trial on behalf of the Ford Motor Company on insurance subrogation claim brought by an insurance company against Ford based on claims of a defective ignition switch.{{ FIELD }}Secured summary judgment for Ford Motor Company against plaintiff’s product liability claim based on allegations that a defective seatbelt caused plaintiff to sustain injuries during an automobile accident.{{ FIELD }}Secured a defense judgment on behalf of a foreign gas tank manufacturer in a personal injury case brought by several plaintiffs who sustained personal injuries when their personal watercraft exploded causing several of the plaintiffs to claim brain damage, partial blindness and severe emotional distress.{{ FIELD }}Government Tort Liability\nRepresented the Bay Area Rapid Transit District (BART) in various personal injury and property damage claims arising from construction activities occurring during the BART extension projects.{{ FIELD }}Troy McMahan has more than 30 years of experience defending Fortune 500 companies in cases involving premises and products liability claims, toxic tort claims, maritime claims and business disputes involving the improper use of proprietary information. He serves as counsel for multiple corporations and organizations across a broad range of industries including Chevron, Texaco, and Dow.\nTroy often acts as jointly retained counsel for multiple industry defendants and has years of experience in structuring and managing such joint defenses.\nTroy has extensive experience litigating product and premises liability dockets throughout the U.S. including California. He specializes in toxic tort cases involving claims of contaminants exposure from the workplace or through consumer goods. Troy also has special expertise in product liability defense for automobile manufacturers in cases involving automotive design and manufacture. He has tried jury cases to verdict involving asbestos-containing brake products, and has secured defense verdicts for automobile manufacturers in cases alleging that a defective ignition switch caused a vehicle fire and subsequent property damage, as well as a case alleging violations of the California Song Beverly Consumer Warranty Act. \nTroy has received recognition as a top rated products liability attorney on numerous occasions by Super Lawyers, and he has been invited to be a guest instructor for a course entitled \"Depositions - Witness Preparation\" at the University of California, Berkeley, School of Law (Feb. 2024). Counsel Selected to Super Lawyers (2006, 2010-2015, 2020) Super Lawyers University of Idaho University of Idaho College of Law University of Utah S.J. Quinney College of Law U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California California Bar Association of San Francisco Alameda County Bar Association Association of Defense Counsel American Bar Association — Environmental, Product Liability and Mass Tort Sections member Defense Research Institute — Drug and Medical Device, Product Liability and Toxic Tort Committees member Food and Beverage\nRepresented an egg producer in connection with commercial claims arising from a 2010 salmonella outbreak and recall (the largest egg salmonella outbreak in history) and related FDA investigation. Toxic Tort\nCounsel for crude oil refiners and manufacturers of industrial commercial and consumer grade chemical products in personal injury and wrongful death cases involving cancer, systemic diseases and immune system dysfunction. Maritime\nRepresent vessel owners and operators in matters involving wrongful death and personal injury cases filed by seaman, longshoreman and shipyard contractors under federal maritime law — Jones Act, Longshoreman and Harbor Workers’ Compensation Act and federal maritime common law. Secured summary judgment for a shipping client in a case of first impression — whether federal maritime law imposes a duty upon a ship owner to protect offshore third parties from injuries occurring as a result of activities performed aboard ship. Specifically, plaintiff claimed exposure to toxins used aboard the vessel, and which his father — an officer aboard the vessel — allegedly brought home on his uniform. Asbestos\nRepresent Chevron U.S.A. Inc., Texaco Inc., and The Dow Chemical Company in trial asbestos product and premises liability dockets throughout the State of California. Automotive\nSecured a defense verdict at trial on behalf of the Ford Motor Company on insurance subrogation claim brought by an insurance company against Ford based on claims of a defective ignition switch. Secured summary judgment for Ford Motor Company against plaintiff’s product liability claim based on allegations that a defective seatbelt caused plaintiff to sustain injuries during an automobile accident. Secured a defense judgment on behalf of a foreign gas tank manufacturer in a personal injury case brought by several plaintiffs who sustained personal injuries when their personal watercraft exploded causing several of the plaintiffs to claim brain damage, partial blindness and severe emotional distress. Government Tort Liability\nRepresented the Bay Area Rapid Transit District (BART) in various personal injury and property damage claims arising from construction activities occurring during the BART extension projects.","searchable_name":"Troy D. McMahan","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":196,"capability_group_featured":null,"home_page_featured":null},{"id":448899,"version":1,"owner_type":"Person","owner_id":1253,"payload":{"bio":"\u003cp\u003eMegan Michelsen is a lawyer with King \u0026amp; Spalding\u0026rsquo;s Mass Tort and Toxic Tort practice. Her practice focuses mainly on the representation of clients in the pharmaceutical industry and other FDA-regulated clients. She has experience with large-scale, multidistrict litigations as well as individual product liability actions.\u003c/p\u003e","slug":"megan-michelsen","email":"mmichelsen@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":1,"guid":"1.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":4,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":5,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":6,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":7,"source":"capabilities"},{"id":1256,"guid":"1256.smart_tags","index":8,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Michelsen","nick_name":"Megan","clerkships":[],"first_name":"Megan","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"M.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eMegan Michelsen is a lawyer with King \u0026amp; Spalding\u0026rsquo;s Mass Tort and Toxic Tort practice. Her practice focuses mainly on the representation of clients in the pharmaceutical industry and other FDA-regulated clients. She has experience with large-scale, multidistrict litigations as well as individual product liability actions.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1062}]},"capability_group_id":3},"created_at":"2026-05-28T22:09:41.000Z","updated_at":"2026-05-28T22:09:41.000Z","searchable_text":"Michelsen{{ FIELD }}Megan Michelsen is a lawyer with King \u0026amp; Spalding’s Mass Tort and Toxic Tort practice. Her practice focuses mainly on the representation of clients in the pharmaceutical industry and other FDA-regulated clients. She has experience with large-scale, multidistrict litigations as well as individual product liability actions. Associate McDaniel College  University of Maryland University of Maryland School of Law Georgia State Bar of Georgia","searchable_name":"Megan M. Michelsen","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":448641,"version":1,"owner_type":"Person","owner_id":2069,"payload":{"bio":"\u003cp\u003eRadha Manthe is an associate in the Atlanta office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Trial \u0026amp; Global Disputes practice. Her practice concentrates on representing clients in the pharmaceutical industry in nationwide product liability, mass tort, and personal injury litigation. She has experience in large-scale, multi-district litigation as well as individual product liability actions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRadha is also committed to \u003cem\u003epro bono\u003c/em\u003e work, including, representing asylum clients with the Georgia Asylum and Immigration Network (GAIN), representing tenants in disputes with their landlords through the Atlanta Volunteer Lawyers Foundations\u0026rsquo; (AVLF) Standing With Our Neighbors initiative, \u0026nbsp;and representing a non-profit organization in a wrongful death lawsuit.\u003c/p\u003e\n\u003cp\u003eRadha serves on the Board of Directors for GAIN and is active with Omega Phi Alpha National Service Sorority.\u003c/p\u003e","slug":"radha-manthe","email":"rmanthe@kslaw.com","phone":null,"matters":["\u003cp\u003eMember of national coordinating and trial counsel team representing \u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e (\u0026ldquo;GSK\u0026rdquo;) in nationwide product liability litigation concerning allegations of a link between the company\u0026rsquo;s antidepressant, Paxil\u0026reg;, and an increased risk of certain congenital defects; an increased risk of suicidality in adult and pediatric patients; an increased risk of an autism spectrum disorder if used during pregnancy; and an increased risk of cardiac valve injury. Radha\u0026rsquo;s experience includes: trial preparation; formulating and executing litigation strategy; preparing company witnesses for deposition; deposing plaintiffs\u0026rsquo; family members and treating physicians; briefing dispositive and procedural motions; and coordinating discovery, including written discovery and discovery motions. Radha\u0026rsquo;s involvement has included litigating in federal and state courts in numerous states, including California, Illinois, Louisiana, Minnesota, Mississippi, Missouri, Ohio, Pennsylvania, and South Dakota.\u003c/p\u003e","\u003cp\u003eObtained summary judgment for GSK in a case alleging that Paxil\u0026reg; caused a congenital cardiac defect. The Court granted GSK's summary judgment motion based on North Carolina\u0026rsquo;s learned intermediary doctrine and lack of causation. (Mullins v. GSK, No. 3564, Phila. Ct. Com. Pl.)\u003c/p\u003e","\u003cp\u003eObtained summary judgment for GSK in a case alleging that Paxil\u0026reg; caused cardiac valve injury. The Court granted GSK\u0026rsquo;s summary judgment motion on prescription/statute of limitations. (McLaughlin v. GSK, No. 12-2964, W.D. La.)\u003c/p\u003e","\u003cp\u003eMember of national trial counsel team representing an international medical device company in female pelvic mesh litigation.\u0026nbsp; Radha\u0026rsquo;s experience includes trial preparation, mass tort coordination, case assessment for resolution, preparing company witnesses for deposition, procedural motions, and coordinating written discovery.\u003c/p\u003e","\u003cp\u003eMember of national coordinating counsel representing \u003cstrong\u003eAstraZeneca\u003c/strong\u003e in nationwide product liability litigation concerning allegations regarding the company\u0026rsquo;s statin, Crestor\u0026reg;. This litigation involves claims that treatment with Crestor\u0026reg; caused or contributed to the development of diabetes, rhabdomyolosis, renal damage, and cardiovascular injuries. Radha\u0026rsquo;s experience includes creating protocol for ESI predictive coding, researching scientific issues, and procedural motions.\u003c/p\u003e","\u003cp\u003eMember of team representing Merck Sharpe \u0026amp; Dohme Corp. in litigation concerning allegations of injuries arising from use of the company\u0026rsquo;s osteoporosis medication. Radha\u0026rsquo;s experience includes trial preparation and coordinating discovery.\u003c/p\u003e","\u003cp\u003eMember of team representing a large school district pursuing claims of breach of contract, breach of fiduciary duty, fraud, and state RICO violations against a program management firm hired to manage the district\u0026rsquo;s $1 billion construction program. Radha\u0026rsquo;s experience includes appellate briefing; trial preparation; formulating and executing litigation strategy; arguing summary judgment and discovery motions; briefing dispositive, procedural, and discovery motions; preparing for and conducting depositions; and coordinating discovery.\u003c/p\u003e","\u003cp\u003eObtained dismissal of a wrongful death lawsuit for a non-profit organization in a \u003cem\u003epro bono\u003c/em\u003e matter. Radha formulated and executed the litigation strategy; prepared and defended organization witnesses for depositions; conducted plaintiffs\u0026rsquo; and other defendants\u0026rsquo; depositions; and coordinated discovery.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":17,"guid":"17.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":2,"source":"smartTags"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":4,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":5,"source":"capabilities"},{"id":1158,"guid":"1158.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Manthe","nick_name":"Radha","clerkships":[],"first_name":"Radha","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"Sathe","name_suffix":"","recognitions":[{"title":"ADL Young Lawyer Award","detail":"Anti-Defamation League Southeast Region, 2018"},{"title":"Volunteer of the Year","detail":"Pro Bono Partnership of Atlanta, 2012"}],"linked_in_url":"www.linkedin.com/in/radha-manthe-781854229","seodescription":null,"primary_title_id":122,"translated_fields":{"en":{"bio":"\u003cp\u003eRadha Manthe is an associate in the Atlanta office of King \u0026amp; Spalding and a member of the firm\u0026rsquo;s Trial \u0026amp; Global Disputes practice. Her practice concentrates on representing clients in the pharmaceutical industry in nationwide product liability, mass tort, and personal injury litigation. She has experience in large-scale, multi-district litigation as well as individual product liability actions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRadha is also committed to \u003cem\u003epro bono\u003c/em\u003e work, including, representing asylum clients with the Georgia Asylum and Immigration Network (GAIN), representing tenants in disputes with their landlords through the Atlanta Volunteer Lawyers Foundations\u0026rsquo; (AVLF) Standing With Our Neighbors initiative, \u0026nbsp;and representing a non-profit organization in a wrongful death lawsuit.\u003c/p\u003e\n\u003cp\u003eRadha serves on the Board of Directors for GAIN and is active with Omega Phi Alpha National Service Sorority.\u003c/p\u003e","matters":["\u003cp\u003eMember of national coordinating and trial counsel team representing \u003cstrong\u003eGlaxoSmithKline\u003c/strong\u003e (\u0026ldquo;GSK\u0026rdquo;) in nationwide product liability litigation concerning allegations of a link between the company\u0026rsquo;s antidepressant, Paxil\u0026reg;, and an increased risk of certain congenital defects; an increased risk of suicidality in adult and pediatric patients; an increased risk of an autism spectrum disorder if used during pregnancy; and an increased risk of cardiac valve injury. Radha\u0026rsquo;s experience includes: trial preparation; formulating and executing litigation strategy; preparing company witnesses for deposition; deposing plaintiffs\u0026rsquo; family members and treating physicians; briefing dispositive and procedural motions; and coordinating discovery, including written discovery and discovery motions. Radha\u0026rsquo;s involvement has included litigating in federal and state courts in numerous states, including California, Illinois, Louisiana, Minnesota, Mississippi, Missouri, Ohio, Pennsylvania, and South Dakota.\u003c/p\u003e","\u003cp\u003eObtained summary judgment for GSK in a case alleging that Paxil\u0026reg; caused a congenital cardiac defect. The Court granted GSK's summary judgment motion based on North Carolina\u0026rsquo;s learned intermediary doctrine and lack of causation. (Mullins v. GSK, No. 3564, Phila. Ct. Com. Pl.)\u003c/p\u003e","\u003cp\u003eObtained summary judgment for GSK in a case alleging that Paxil\u0026reg; caused cardiac valve injury. The Court granted GSK\u0026rsquo;s summary judgment motion on prescription/statute of limitations. (McLaughlin v. GSK, No. 12-2964, W.D. La.)\u003c/p\u003e","\u003cp\u003eMember of national trial counsel team representing an international medical device company in female pelvic mesh litigation.\u0026nbsp; Radha\u0026rsquo;s experience includes trial preparation, mass tort coordination, case assessment for resolution, preparing company witnesses for deposition, procedural motions, and coordinating written discovery.\u003c/p\u003e","\u003cp\u003eMember of national coordinating counsel representing \u003cstrong\u003eAstraZeneca\u003c/strong\u003e in nationwide product liability litigation concerning allegations regarding the company\u0026rsquo;s statin, Crestor\u0026reg;. This litigation involves claims that treatment with Crestor\u0026reg; caused or contributed to the development of diabetes, rhabdomyolosis, renal damage, and cardiovascular injuries. Radha\u0026rsquo;s experience includes creating protocol for ESI predictive coding, researching scientific issues, and procedural motions.\u003c/p\u003e","\u003cp\u003eMember of team representing Merck Sharpe \u0026amp; Dohme Corp. in litigation concerning allegations of injuries arising from use of the company\u0026rsquo;s osteoporosis medication. Radha\u0026rsquo;s experience includes trial preparation and coordinating discovery.\u003c/p\u003e","\u003cp\u003eMember of team representing a large school district pursuing claims of breach of contract, breach of fiduciary duty, fraud, and state RICO violations against a program management firm hired to manage the district\u0026rsquo;s $1 billion construction program. Radha\u0026rsquo;s experience includes appellate briefing; trial preparation; formulating and executing litigation strategy; arguing summary judgment and discovery motions; briefing dispositive, procedural, and discovery motions; preparing for and conducting depositions; and coordinating discovery.\u003c/p\u003e","\u003cp\u003eObtained dismissal of a wrongful death lawsuit for a non-profit organization in a \u003cem\u003epro bono\u003c/em\u003e matter. Radha formulated and executed the litigation strategy; prepared and defended organization witnesses for depositions; conducted plaintiffs\u0026rsquo; and other defendants\u0026rsquo; depositions; and coordinated discovery.\u003c/p\u003e"],"recognitions":[{"title":"ADL Young Lawyer Award","detail":"Anti-Defamation League Southeast Region, 2018"},{"title":"Volunteer of the Year","detail":"Pro Bono Partnership of Atlanta, 2012"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1029}]},"capability_group_id":3},"created_at":"2026-05-28T21:50:20.000Z","updated_at":"2026-05-28T21:50:20.000Z","searchable_text":"Manthe{{ FIELD }}{:title=\u0026gt;\"ADL Young Lawyer Award\", :detail=\u0026gt;\"Anti-Defamation League Southeast Region, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Volunteer of the Year\", :detail=\u0026gt;\"Pro Bono Partnership of Atlanta, 2012\"}{{ FIELD }}Member of national coordinating and trial counsel team representing GlaxoSmithKline (“GSK”) in nationwide product liability litigation concerning allegations of a link between the company’s antidepressant, Paxil®, and an increased risk of certain congenital defects; an increased risk of suicidality in adult and pediatric patients; an increased risk of an autism spectrum disorder if used during pregnancy; and an increased risk of cardiac valve injury. Radha’s experience includes: trial preparation; formulating and executing litigation strategy; preparing company witnesses for deposition; deposing plaintiffs’ family members and treating physicians; briefing dispositive and procedural motions; and coordinating discovery, including written discovery and discovery motions. Radha’s involvement has included litigating in federal and state courts in numerous states, including California, Illinois, Louisiana, Minnesota, Mississippi, Missouri, Ohio, Pennsylvania, and South Dakota.{{ FIELD }}Obtained summary judgment for GSK in a case alleging that Paxil® caused a congenital cardiac defect. The Court granted GSK's summary judgment motion based on North Carolina’s learned intermediary doctrine and lack of causation. (Mullins v. GSK, No. 3564, Phila. Ct. Com. Pl.){{ FIELD }}Obtained summary judgment for GSK in a case alleging that Paxil® caused cardiac valve injury. The Court granted GSK’s summary judgment motion on prescription/statute of limitations. (McLaughlin v. GSK, No. 12-2964, W.D. La.){{ FIELD }}Member of national trial counsel team representing an international medical device company in female pelvic mesh litigation.  Radha’s experience includes trial preparation, mass tort coordination, case assessment for resolution, preparing company witnesses for deposition, procedural motions, and coordinating written discovery.{{ FIELD }}Member of national coordinating counsel representing AstraZeneca in nationwide product liability litigation concerning allegations regarding the company’s statin, Crestor®. This litigation involves claims that treatment with Crestor® caused or contributed to the development of diabetes, rhabdomyolosis, renal damage, and cardiovascular injuries. Radha’s experience includes creating protocol for ESI predictive coding, researching scientific issues, and procedural motions.{{ FIELD }}Member of team representing Merck Sharpe \u0026amp; Dohme Corp. in litigation concerning allegations of injuries arising from use of the company’s osteoporosis medication. Radha’s experience includes trial preparation and coordinating discovery.{{ FIELD }}Member of team representing a large school district pursuing claims of breach of contract, breach of fiduciary duty, fraud, and state RICO violations against a program management firm hired to manage the district’s $1 billion construction program. Radha’s experience includes appellate briefing; trial preparation; formulating and executing litigation strategy; arguing summary judgment and discovery motions; briefing dispositive, procedural, and discovery motions; preparing for and conducting depositions; and coordinating discovery.{{ FIELD }}Obtained dismissal of a wrongful death lawsuit for a non-profit organization in a pro bono matter. Radha formulated and executed the litigation strategy; prepared and defended organization witnesses for depositions; conducted plaintiffs’ and other defendants’ depositions; and coordinated discovery.{{ FIELD }}Radha Manthe is an associate in the Atlanta office of King \u0026amp; Spalding and a member of the firm’s Trial \u0026amp; Global Disputes practice. Her practice concentrates on representing clients in the pharmaceutical industry in nationwide product liability, mass tort, and personal injury litigation. She has experience in large-scale, multi-district litigation as well as individual product liability actions.\nRadha is also committed to pro bono work, including, representing asylum clients with the Georgia Asylum and Immigration Network (GAIN), representing tenants in disputes with their landlords through the Atlanta Volunteer Lawyers Foundations’ (AVLF) Standing With Our Neighbors initiative,  and representing a non-profit organization in a wrongful death lawsuit.\nRadha serves on the Board of Directors for GAIN and is active with Omega Phi Alpha National Service Sorority. Pro Bono Deputy ADL Young Lawyer Award Anti-Defamation League Southeast Region, 2018 Volunteer of the Year Pro Bono Partnership of Atlanta, 2012 Georgia Institute of Technology  University of Virginia University of Virginia School of Law U.S. District Court for the Middle District of Georgia U.S. District Court for the Northern District of Georgia Georgia Court of Appeals of Georgia Supreme Court of Georgia Member of national coordinating and trial counsel team representing GlaxoSmithKline (“GSK”) in nationwide product liability litigation concerning allegations of a link between the company’s antidepressant, Paxil®, and an increased risk of certain congenital defects; an increased risk of suicidality in adult and pediatric patients; an increased risk of an autism spectrum disorder if used during pregnancy; and an increased risk of cardiac valve injury. Radha’s experience includes: trial preparation; formulating and executing litigation strategy; preparing company witnesses for deposition; deposing plaintiffs’ family members and treating physicians; briefing dispositive and procedural motions; and coordinating discovery, including written discovery and discovery motions. Radha’s involvement has included litigating in federal and state courts in numerous states, including California, Illinois, Louisiana, Minnesota, Mississippi, Missouri, Ohio, Pennsylvania, and South Dakota. Obtained summary judgment for GSK in a case alleging that Paxil® caused a congenital cardiac defect. The Court granted GSK's summary judgment motion based on North Carolina’s learned intermediary doctrine and lack of causation. (Mullins v. GSK, No. 3564, Phila. Ct. Com. Pl.) Obtained summary judgment for GSK in a case alleging that Paxil® caused cardiac valve injury. The Court granted GSK’s summary judgment motion on prescription/statute of limitations. (McLaughlin v. GSK, No. 12-2964, W.D. La.) Member of national trial counsel team representing an international medical device company in female pelvic mesh litigation.  Radha’s experience includes trial preparation, mass tort coordination, case assessment for resolution, preparing company witnesses for deposition, procedural motions, and coordinating written discovery. Member of national coordinating counsel representing AstraZeneca in nationwide product liability litigation concerning allegations regarding the company’s statin, Crestor®. This litigation involves claims that treatment with Crestor® caused or contributed to the development of diabetes, rhabdomyolosis, renal damage, and cardiovascular injuries. Radha’s experience includes creating protocol for ESI predictive coding, researching scientific issues, and procedural motions. Member of team representing Merck Sharpe \u0026amp; Dohme Corp. in litigation concerning allegations of injuries arising from use of the company’s osteoporosis medication. Radha’s experience includes trial preparation and coordinating discovery. Member of team representing a large school district pursuing claims of breach of contract, breach of fiduciary duty, fraud, and state RICO violations against a program management firm hired to manage the district’s $1 billion construction program. Radha’s experience includes appellate briefing; trial preparation; formulating and executing litigation strategy; arguing summary judgment and discovery motions; briefing dispositive, procedural, and discovery motions; preparing for and conducting depositions; and coordinating discovery. Obtained dismissal of a wrongful death lawsuit for a non-profit organization in a pro bono matter. Radha formulated and executed the litigation strategy; prepared and defended organization witnesses for depositions; conducted plaintiffs’ and other defendants’ depositions; and coordinated discovery.","searchable_name":"Radha Sathe Manthe","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null}]}}